rare diseases
rare diseases
AstraZeneca’s $2 Billion Boost for Maryland Jobs!
🌟 AstraZeneca invests $2 billion in Maryland! 🏭 Expanding facilities, creating 2,600 jobs, and focusing on rare diseases! 🔬🌱✨
Breakthrough Gene Therapy for Children’s Vision Loss!
🌟 Andelyn Biosciences partners with Tern Therapeutics to manufacture TTX-381, a gene therapy for children with vision loss. 👁️🚀
Game-Changer: miRecule and GBI Join Forces for ARC Therapies!
🚀 miRecule and GBI Biomanufacturing team up to enhance ARC therapies, addressing rare diseases with innovative bioconjugate treatments! 🔬✨🤝
Lonza Launches First GMP Batch at New Facility!
🌟 Lonza's first GMP batch at its new Portsmouth facility marks a leap in biomanufacturing, supporting innovative therapies! 💊🚀🔧
Revolutionizing Drug Access with Quantum Micromanufacturing!
Unlocking affordable therapeutics! 🌍✨ Quantum AI-driven micromanufacturing ensures sustainable, efficient production of essential treatments for rare diseases. 💊⚙️
Breaking News: UK Innovation Hubs Revolutionize Gene Therapies
📢 U.K. Innovation Hubs for Gene Therapies Now Open! 🧬 Offering services to academia and industry, focusing on rare diseases. 🏭💼
Game-Changing RNA Vaccine Success: How One Company Perfected Manufacturing
📰 Arcturus Therapeutics, the pioneer in self-amplifying mRNA (saRNA) vaccines, credits perfecting manufacturing techniques for success. 💉🏭🔬
